- Home
- AZN vs WELL Comparison
AZN vs WELL Comparison
Compare AZN & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZN | WELL |
|---|---|---|
| Founded | 1992 | 1970 |
| Country | United Kingdom | United States |
| Employees | 96100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 136.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | AZN | WELL |
|---|---|---|
| Price | $201.01 | $210.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $224.38 |
| AVG Volume (30 Days) | 1.8M | ★ 2.4M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.57% | 1.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | N/A | ★ $10,838,034,000.00 |
| Revenue This Year | $10.35 | $28.66 |
| Revenue Next Year | $6.43 | $6.03 |
| P/E Ratio | ★ $31.91 | $151.66 |
| Revenue Growth | N/A | ★ 35.63 |
| 52 Week Low | $66.16 | $141.55 |
| 52 Week High | $212.71 | $216.43 |
Technical Indicators
Market Signals| Indicator | AZN | WELL |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 64.44 |
| Support Level | $182.39 | $182.12 |
| Resistance Level | $211.32 | $215.49 |
| Average True Range (ATR) | 3.62 | 3.77 |
| MACD | 0.08 | 1.31 |
| Stochastic Oscillator | 74.95 | 95.97 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.